MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 309, Issue 11, 2015, Pages H1813-H1826

  Higashi, Kenshi ^a   Yamada, Yoshihisa ^a   Minatoguchi, Shingo ^a   Baba, Shinya ^a   Iwasa, Masamitsu ^a   Kanamori, Hiromitsu ^a   Kawasaki, Masanori ^a   Nishigaki, Kazuhiko ^a   Takemura, Genzou ^a   Kumazaki, Minami ^b   Akao, Yukihiro ^b   Minatoguchi, Shinya ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

Autophagy; Cardiomyocyte; MiR 145; Myocardial infarction

Indexed keywords

ANTAGOMIR; CHLOROQUINE; FIBROBLAST GROWTH FACTOR RECEPTOR 2; LIPOSOME; MESSENGER RNA; MICRORNA 145; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN KINASE B; PROTEIN LC3B I; PROTEIN LC3B II; PROTEIN P62; UNCLASSIFIED DRUG; FIBROBLAST RECEPTOR SUBSTRATE 2, RAT; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 4; LC3 PROTEIN, RAT; MICRORNA; MICROTUBULE ASSOCIATED PROTEIN; MIRN145 MICRORNA, RAT; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL GROWTH; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; DIASTOLIC BLOOD PRESSURE; DOWN REGULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG TISSUE LEVEL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; HEMODYNAMIC PARAMETERS; IN VITRO STUDY; IN VIVO STUDY; MALE; MORTALITY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RABBIT MODEL; RAT; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING; ANIMAL; CARDIAC MUSCLE CELL; CELL LINE; DISEASE MODEL; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HEART VENTRICLE REMODELING; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROCEDURES; RABBIT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AUTOPHAGY; CELL LINE; DISEASE MODELS, ANIMAL; GENETIC THERAPY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICRORNAS; MICROTUBULE-ASSOCIATED PROTEINS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RABBITS; RATS; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84949310237     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00709.2014     Document Type: Article

References (28)

1. Ambros V. The functions of animal microRNAs. Nature 431: 350–335, 2004.
2. Chen K, Rajewski N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8: 93–103, 2007.
3. Cheng Y, Liu X, Yang J, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105: 158–166, 2009.
4. Dubbelhuis PF, Van Sluijters DA, Blommaart EFC, Gustafson LA, Van Woerkom GM, Herling AW, Burger HJ, Meijer AJ. Inhibition of autophagic proteolysis by inhibitors of phosphoinositide 3-kinase can interfere with the regulation of glycogen synthesis in isolated hepatocytes. Biochem J 368: 827–833, 2002.
5. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16: 139–149, 2005.
6. Hausenly DJ, Tsang A, Mocanu MM, Yellon DM. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 288: H971–H976, 2005.
7. Horwitz LD, Fennessey PV, Shikes RH, Kong Y. Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion. Circulation 89: 1792–1801, 1994.
8. Huang C, Yitzhaki S, Perry CN, Liu W, Giricz Z, Mentzer RM Jr, Gottlieb RA. Autophagy induced by ischemic preconditioning is essential for cardioprotection. J Cardiovasc Transl Res 3: 365–373, 2010.
9. Iwai-Kanai E, Yuan H, Huang C, Sayen MR, Perry-Garza CN, Kim L, Gottlieb RA. A method to measure cardiac autophagic flux in vivo. Autophagy 4: 322–329, 2008.
10. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 100: 1579–1588, 2007.
11. Kanamori H, Takemura G, Goto K, Maruyama R, Ono K, Nagao K, Tsujimoto A, Ogino A, Takeyama T, Kawaguchi T, Watanabe T, Kawasaki M, Fujiwara T, Fujiwara H, Seishima M, Minatoguchi S. Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion. Am J Physiol Heart Circ Physiol 300: H2261–H2271, 2011.
12. Li R, Yan G, Li Q, Sun H, Hu Y, Sun J, Xu B. MicroRNA-145 protects cardiomyocytes against hydrogen peroxide (H2O2)-induced apoptosis through targeting the mitochondrial apoptotic pathway. PLoS One 7: e44907, 2012.
13. Luo LY, Kim E, Cheung HW, Weir BA, Dunn GP, Shen RR, Hahn WC. The tyrosine kinase adaptor protein FRS2 is oncogenic and amplified in high-grade serous ovarian cancer. Mol Cancer Res 13: 502–509, 2015.
14. Luo T, Liu G, Ma H, Lu B, Xu H, Wang Y, Wu J, Ge P, Liang J. Inhibition of autophagy via activation of PI3K/Akt pathway contributes to the protection of ginsenoside Rb1 against neuronal death caused by ischemic insults. Int J Mol Sci 15: 15426–15442, 2014.
15. Minatoguchi S, Arai M, Uno Y, Kariya T, Nishida Y, Hashimoto K, Kawasaki M, Takemura G, Fujiwara T, Fujiwara H. A novel antidiabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits. Br J Pharmacol 128: 1667–1672, 1999.
16. Moyzis AG, Sadoshima J, Gustafsson AB. Mending a broken heart: the role of mitophagy in cardioprotection. Am J Physiol Heart Circ Physiol 308: H183–H192, 2015.
17. Orogo AM, Gustafsson ÅB. Therapeutic targeting of autophagy: potential and concerns in treating cardiovascular disease. Circ Res 116: 489–503, 2015.
18. Penna C, Mancardi S, Raimondo S, Geuna S, Pagliaro P. The paradigm of postconditioning to protect the heart. J Cell Mol Med 12: 435–458, 2008.
19. Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardial at risk) and collateral flow. Lab Invest 40: 633–644, 1979.
20. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 95: 230–232, 2004.
21. Wei Y, Schober A, Weber C. Pathogenic arterial remodeling: the good and bad of microRNAs. Am J Physiol Heart Circ Physiol 304: H1050–H1059, 2013.
22. Xie M, Morales CR, Lavandero S, Hill JA. Tuning flux: autophagy as a target of heart disease therapy. Curr Opin Cardiol 26: 216–222, 2011.
23. Yamada Y, Kobayashi H, Iwasa M, Sumi S, Ushikoshi H, Aoyama T, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Kiso M, Minatoguchi S. Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with siaryl Lewis X repairs infarcted myocardium in rabbits. Am J Physiol Heart Circ Physiol 304: H1124–H1133, 2013.
24. Zhang J, Liu J, Huang Y, Chang JY, Liu L, McKeehan WL, Martin JF, Wang F. FRS2α-mediated FGF signals suppress premature differentiation of cardiac stem cells through regulating autophagy activity. Circ Res 110: e29–e39, 2012.
25. Zhang J, Liu J, Liu L, McKeehan WL, Wang F. The fibroblast growth factor signaling axis controls cardiac stem cell differentiation through regulating autophagy. Autophagy 8: 690–691, 2012.
26. Zhang K, Chu K, Wu X, Gao H, Wang J, Yuan YC, Loera S, Ho K, Wang Y, Chow W, Un F, Chu P, Yen Y. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma. Cancer Res 73: 1298–1307, 2013.
27. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H578–H588, 2003.
28. Zhou W, Feng X, Wu Y, Benge J, Zhang Z, Chen Z. FGF-receptor substrate 2 functions as a molecular sensor integrating external regulatory signals into the FGF pathway. Cell Res 19: 1165–1177, 2009.